Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $1.78 in the prior trading day, Tango Therapeutics Inc (NASDAQ: TNGX) closed at $1.76, down -1.12%. In other words, the price has decreased by -$1.12 from its previous closing price. On the day, 1.14 million shares were traded. TNGX stock price reached its highest trading level at $1.79 during the session, while it also had its lowest trading level at $1.655.
Ratios:
Our goal is to gain a better understanding of TNGX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.98 and its Current Ratio is at 6.98. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 17, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On February 12, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $18.Piper Sandler initiated its Overweight rating on February 12, 2024, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 04 ’25 when Barry Douglas sold 2,774 shares for $2.99 per share. The transaction valued at 8,289 led to the insider holds 68,570 shares of the business.
Barry Douglas sold 2,556 shares of TNGX for $8,081 on Feb 05 ’25. The General Counsel now owns 66,014 shares after completing the transaction at $3.16 per share. On Feb 04 ’25, another insider, Beckman Daniella, who serves as the Chief Financial Officer of the company, sold 4,284 shares for $2.99 each. As a result, the insider received 12,801 and left with 154,232 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNGX now has a Market Capitalization of 190270080 and an Enterprise Value of -31154114. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.52 while its Price-to-Book (P/B) ratio in mrq is 0.95. Its current Enterprise Value per Revenue stands at -0.741 whereas that against EBITDA is 0.218.
Stock Price History:
The Beta on a monthly basis for TNGX is 0.92, which has changed by -0.7693316 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, TNGX has reached a high of $12.02, while it has fallen to a 52-week low of $1.68. The 50-Day Moving Average of the stock is -29.70%, while the 200-Day Moving Average is calculated to be -70.61%.
Shares Statistics:
The stock has traded on average 744.03K shares per day over the past 3-months and 749420 shares per day over the last 10 days, according to various share statistics. A total of 107.73M shares are outstanding, with a floating share count of 59.12M. Insiders hold about 45.31% of the company’s shares, while institutions hold 55.99% stake in the company. Shares short for TNGX as of 1740700800 were 7036859 with a Short Ratio of 9.46, compared to 1738281600 on 5441461. Therefore, it implies a Short% of Shares Outstanding of 7036859 and a Short% of Float of 11.93.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
